[Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab]
| Autor: | L. A. Tsukurova, Sivertseva Sa, Valentina M. Alifirova, N A Malkova, I.Y. Solodun, M. N. Zakharova, I. N. Pronin, E. P. Evdoshenko, M. V. Davydovskaya, Turova Ea, A. N. Boiko, A.A. Skoromets, Khachanova Nv |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Drug
medicine.medical_specialty Risk management plan business.industry media_common.quotation_subject Multiple sclerosis medicine.disease 03 medical and health sciences Psychiatry and Mental health 0302 clinical medicine Natalizumab medicine 030212 general & internal medicine Neurology (clinical) Intensive care medicine business 030217 neurology & neurosurgery media_common medicine.drug |
| Zdroj: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(10 Pt 2) |
| ISSN: | 1997-7298 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|